Skip to main content
Top
Published in: BMC Medical Informatics and Decision Making 1/2017

Open Access 01-12-2017 | Research Article

A Bayesian network and heuristic approach for systematic characterization of radiotherapy receipt after breast-conservation surgery

Authors: Milton Soto-Ferrari, Diana Prieto, Gitonga Munene

Published in: BMC Medical Informatics and Decision Making | Issue 1/2017

Login to get access

Abstract

Background

Breast-conservation surgery with radiotherapy is a treatment highly recommended by the guidelines from the National Comprehensive Cancer Network. However, several variables influence the final receipt of radiotherapy and it might not be administered to breast cancer patients. Our objective is to propose a systematic framework to identify the clinical and non-clinical variables that influence the receipt of unexpected radiotherapy treatment by means of Bayesian networks and a proposed heuristic approach.

Methods

We used cancer registry data of Detroit, San Francisco-Oakland, and Atlanta from years 2007–2012 downloaded from the Surveillance, Epidemiology, and End Results Program. The samples had patients diagnosed with in situ and early invasive cancer with 14 clinical and non-clinical variables. Bayesian networks were fitted to the data of each region and systematically analyzed through the proposed Zoom-in heuristic. A comparative analysis with logistic regressions is also presented.

Results

For Detroit, patients under stage 0, grade undetermined, histology lobular carcinoma in situ, and age between 26−50 were found more likely to receive breast-conservation surgery without radiotherapy. For stages I, IIA, and IIB patients with age between 51−75, and grade II were found to be more likely to receive breast-conservation surgery with radiotherapy. For San Francisco-Oakland, patients under stage 0, grade undetermined, and age >75 are more likely to receive BCS. For stages I, IIA, and IIB patients with age >75 are more likely to receive breast-conservation surgery without radiotherapy. For Atlanta, patients under stage 0, grade undetermined, year 2011, and primary site C509 are more likely to receive breast-conservation surgery without radiotherapy. For stages I, IIA, and IIB patients in year 2011, and grade III are more likely to receive breast-conservation surgery without radiotherapy.

Conclusion

For in situ breast cancer and early invasive breast cancer, the results are in accordance with the guidelines and very well demonstrates the usefulness of the Zoom-in heuristic in systematically characterizing a group receiving a treatment. We found a subset of the population from Detroit with ductal carcinoma in situ for which breast-conservation surgery without radiotherapy was received, but potential reasons for this treatment are still unknown.
Appendix
Available only for authorised users
Literature
1.
go back to reference Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA: Cancer J Clin. 2016; 66(1):7–30. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA: Cancer J Clin. 2016; 66(1):7–30.
2.
go back to reference National Comprehensive Cancer Network: NCCN Clinical Practice Guidelines in Oncology Breast Cancer Version 1. 2016. www.nccn.org. Accessed 01 June 2016. National Comprehensive Cancer Network: NCCN Clinical Practice Guidelines in Oncology Breast Cancer Version 1. 2016. www.​nccn.​org. Accessed 01 June 2016.
3.
go back to reference Early Breast Cancer Trialists’ Collaborative Group, et al.Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10 801 women in 17 randomised trials. Lancet. 2011; 378(9804):1707–16.CrossRef Early Breast Cancer Trialists’ Collaborative Group, et al.Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10 801 women in 17 randomised trials. Lancet. 2011; 378(9804):1707–16.CrossRef
4.
go back to reference Wickberg Å, Holmberg L, Adami HO, Magnuson A, Villman K, Liljegren G. Sector resection with or without postoperative radiotherapy for stage I breast cancer: 20-year results of a randomized trial. J Clin Oncol. 2014; 32(8):791–7.CrossRefPubMed Wickberg Å, Holmberg L, Adami HO, Magnuson A, Villman K, Liljegren G. Sector resection with or without postoperative radiotherapy for stage I breast cancer: 20-year results of a randomized trial. J Clin Oncol. 2014; 32(8):791–7.CrossRefPubMed
5.
go back to reference Katz SJ, Lantz PM, Janz NK, Fagerlin A, Schwartz K, Liu L, Deapen D, Salem B, Lakhani I, Morrow M. Patterns and correlates of local therapy for women with ductal carcinoma-in-situ. J Clin Oncol. 2005; 23(13):3001–7.CrossRefPubMedPubMedCentral Katz SJ, Lantz PM, Janz NK, Fagerlin A, Schwartz K, Liu L, Deapen D, Salem B, Lakhani I, Morrow M. Patterns and correlates of local therapy for women with ductal carcinoma-in-situ. J Clin Oncol. 2005; 23(13):3001–7.CrossRefPubMedPubMedCentral
6.
go back to reference Kelley L, Silverstein M, Guerra L. Analyzing the risk of recurrence after mastectomy for DCIS: a new use for the USC/Van Nuys Prognostic Index. Ann Surg Oncol. 2011; 18(2):459–62.CrossRefPubMed Kelley L, Silverstein M, Guerra L. Analyzing the risk of recurrence after mastectomy for DCIS: a new use for the USC/Van Nuys Prognostic Index. Ann Surg Oncol. 2011; 18(2):459–62.CrossRefPubMed
7.
go back to reference Lipscombe LL, Fischer HD, Yun L, Gruneir A, Austin P, Paszat L, Anderson GM, Rochon PA. Association between tamoxifen treatment and diabetes. Cancer. 2012; 118(10):2615–22.CrossRefPubMed Lipscombe LL, Fischer HD, Yun L, Gruneir A, Austin P, Paszat L, Anderson GM, Rochon PA. Association between tamoxifen treatment and diabetes. Cancer. 2012; 118(10):2615–22.CrossRefPubMed
8.
go back to reference Ramaswamy B, Shapiro CL. Osteopenia and osteoporosis in women with breast cancer. Semin Oncol. 2003; 30(6):763–75.CrossRefPubMed Ramaswamy B, Shapiro CL. Osteopenia and osteoporosis in women with breast cancer. Semin Oncol. 2003; 30(6):763–75.CrossRefPubMed
9.
go back to reference Srokowski TP, Fang S, Duan Z, Buchholz TA, Hortobagyi GN, Goodwin JS, Giordano SH. Completion of adjuvant radiation therapy among women with breast cancer. Cancer. 2008; 113(1):22–9.CrossRefPubMedPubMedCentral Srokowski TP, Fang S, Duan Z, Buchholz TA, Hortobagyi GN, Goodwin JS, Giordano SH. Completion of adjuvant radiation therapy among women with breast cancer. Cancer. 2008; 113(1):22–9.CrossRefPubMedPubMedCentral
10.
go back to reference Schroen AT, Brenin DR, Kelly MD, Knaus WA, Slingluff CL. Impact of patient distance to radiation therapy on mastectomy use in early-stage breast cancer patients. J Clin Oncol. 2005; 23(28):7074–80.CrossRefPubMed Schroen AT, Brenin DR, Kelly MD, Knaus WA, Slingluff CL. Impact of patient distance to radiation therapy on mastectomy use in early-stage breast cancer patients. J Clin Oncol. 2005; 23(28):7074–80.CrossRefPubMed
11.
go back to reference National Comprehensive Cancer Network: NCCN Clinical Practice Guidelines in Oncology Older Adult Oncology Version 1.2016. www.nccn.org. Accessed 01 July 16. National Comprehensive Cancer Network: NCCN Clinical Practice Guidelines in Oncology Older Adult Oncology Version 1.2016. www.​nccn.​org. Accessed 01 July 16.
12.
go back to reference Van Leeuwen BL, Rosenkranz K, Feng LL, Bedrosian I, Hartmann K, Hunt K, Kuerer H, Ross M, Singletary S, Babiera GV, et al. The effect of under-treatment of breast cancer in women 80 years of age and older. Crit Rev Oncol Hematol. 2011; 79(3):315–20.CrossRefPubMed Van Leeuwen BL, Rosenkranz K, Feng LL, Bedrosian I, Hartmann K, Hunt K, Kuerer H, Ross M, Singletary S, Babiera GV, et al. The effect of under-treatment of breast cancer in women 80 years of age and older. Crit Rev Oncol Hematol. 2011; 79(3):315–20.CrossRefPubMed
13.
go back to reference Jatoi I, Proschan MA. Randomized trials of breast-conserving therapy versus mastectomy for primary breast cancer: a pooled analysis of updated results. Am J Clin Oncol. 2005; 28(3):289–94.CrossRefPubMed Jatoi I, Proschan MA. Randomized trials of breast-conserving therapy versus mastectomy for primary breast cancer: a pooled analysis of updated results. Am J Clin Oncol. 2005; 28(3):289–94.CrossRefPubMed
14.
go back to reference Vinh-Hung V, Voordeckers M, Van de Steene J, Soete G, Lamote J, Storme G. Omission of radiotherapy after breast-conserving surgery: survival impact and time trends. Radiother Oncol. 2003; 67(2):147–58.CrossRefPubMed Vinh-Hung V, Voordeckers M, Van de Steene J, Soete G, Lamote J, Storme G. Omission of radiotherapy after breast-conserving surgery: survival impact and time trends. Radiother Oncol. 2003; 67(2):147–58.CrossRefPubMed
15.
go back to reference Freedman RA, He Y, Winer EP, Keating NL. Trends in racial and age disparities in definitive local therapy of early-stage breast cancer. J Clin Oncol. 2009; 27(5):713–9.CrossRefPubMed Freedman RA, He Y, Winer EP, Keating NL. Trends in racial and age disparities in definitive local therapy of early-stage breast cancer. J Clin Oncol. 2009; 27(5):713–9.CrossRefPubMed
16.
go back to reference Motwani SB, Goyal S, Moran MS, Chhabra A, Haffty BG. Ductal carcinoma in situ treated with breast-conserving surgery and radiotherapy: A comparison with ECOG study 5194. Cancer. 2011; 117(6):1156–62.CrossRefPubMed Motwani SB, Goyal S, Moran MS, Chhabra A, Haffty BG. Ductal carcinoma in situ treated with breast-conserving surgery and radiotherapy: A comparison with ECOG study 5194. Cancer. 2011; 117(6):1156–62.CrossRefPubMed
17.
go back to reference Wang SY, Chu H, Shamliyan T, Jalal H, Kuntz KM, Kane RL, Virnig BA. Network meta-analysis of margin threshold for women with ductal carcinoma in situ. J Nat Cancer Inst. 2012; 104(7):507–16.CrossRefPubMedPubMedCentral Wang SY, Chu H, Shamliyan T, Jalal H, Kuntz KM, Kane RL, Virnig BA. Network meta-analysis of margin threshold for women with ductal carcinoma in situ. J Nat Cancer Inst. 2012; 104(7):507–16.CrossRefPubMedPubMedCentral
18.
go back to reference Lee DY, Lewis JL, Wexelman BA, Freedman BC, Ross RE, Tartter PI. The consequence of undertreatment of patients treated with breast conserving therapy for ductal carcinoma in-situ. Am J Surg. 2013; 206(5):790–7.CrossRefPubMed Lee DY, Lewis JL, Wexelman BA, Freedman BC, Ross RE, Tartter PI. The consequence of undertreatment of patients treated with breast conserving therapy for ductal carcinoma in-situ. Am J Surg. 2013; 206(5):790–7.CrossRefPubMed
19.
go back to reference Ravdin PM, Clark GM. A practical application of neural network analysis for predicting outcome of individual breast cancer patients. Breast Cancer Res Treat. 1992; 22(3):285–93.CrossRefPubMed Ravdin PM, Clark GM. A practical application of neural network analysis for predicting outcome of individual breast cancer patients. Breast Cancer Res Treat. 1992; 22(3):285–93.CrossRefPubMed
20.
go back to reference Mangasarian OL, Street WN, Wolberg WH. Breast cancer diagnosis and prognosis via linear programming. Oper Res. 1995; 43(4):570–7.CrossRef Mangasarian OL, Street WN, Wolberg WH. Breast cancer diagnosis and prognosis via linear programming. Oper Res. 1995; 43(4):570–7.CrossRef
21.
go back to reference Jerez-Aragonés JM, Gómez-Ruiz JA, Ramos-Jiménez G, Muñoz-Pérez J, Alba-Conejo E. A combined neural network and decision trees model for prognosis of breast cancer relapse. Artif Intell Med. 2003; 27(1):45–63.CrossRefPubMed Jerez-Aragonés JM, Gómez-Ruiz JA, Ramos-Jiménez G, Muñoz-Pérez J, Alba-Conejo E. A combined neural network and decision trees model for prognosis of breast cancer relapse. Artif Intell Med. 2003; 27(1):45–63.CrossRefPubMed
22.
go back to reference Delen D, Walker G, Kadam A. Predicting breast cancer survivability: a comparison of three data mining methods. Artif Intell Med. 2005; 34(2):113–27.CrossRefPubMed Delen D, Walker G, Kadam A. Predicting breast cancer survivability: a comparison of three data mining methods. Artif Intell Med. 2005; 34(2):113–27.CrossRefPubMed
23.
go back to reference Kahn CE, Roberts LM, Shaffer KA, Haddawy P. Construction of a bayesian network for mammographic diagnosis of breast cancer. Comput Biol Med. 1997; 27(1):19–29.CrossRefPubMed Kahn CE, Roberts LM, Shaffer KA, Haddawy P. Construction of a bayesian network for mammographic diagnosis of breast cancer. Comput Biol Med. 1997; 27(1):19–29.CrossRefPubMed
24.
go back to reference Lisboa PJ, Wong H, Harris P, Swindell R. A bayesian neural network approach for modelling censored data with an application to prognosis after surgery for breast cancer. Artif Intell Med. 2003; 28(1):1–25.CrossRefPubMed Lisboa PJ, Wong H, Harris P, Swindell R. A bayesian neural network approach for modelling censored data with an application to prognosis after surgery for breast cancer. Artif Intell Med. 2003; 28(1):1–25.CrossRefPubMed
25.
go back to reference Gevaert O, De Smet F, Timmerman D, Moreau Y, De Moor B. Predicting the prognosis of breast cancer by integrating clinical and microarray data with bayesian networks. Bioinformatics. 2006; 22(14):184–90.CrossRef Gevaert O, De Smet F, Timmerman D, Moreau Y, De Moor B. Predicting the prognosis of breast cancer by integrating clinical and microarray data with bayesian networks. Bioinformatics. 2006; 22(14):184–90.CrossRef
26.
go back to reference Gerstung M, Baudis M, Moch H, Beerenwinkel N. Quantifying cancer progression with conjunctive bayesian networks. Bioinformatics. 2009; 25(21):2809–15.CrossRefPubMedPubMedCentral Gerstung M, Baudis M, Moch H, Beerenwinkel N. Quantifying cancer progression with conjunctive bayesian networks. Bioinformatics. 2009; 25(21):2809–15.CrossRefPubMedPubMedCentral
27.
go back to reference Nagarajan R, Scutari M, Lèbre S. Bayesian Networks in R: with Applications in Systems Biology. New York: Springer-Verlag; 2013.CrossRef Nagarajan R, Scutari M, Lèbre S. Bayesian Networks in R: with Applications in Systems Biology. New York: Springer-Verlag; 2013.CrossRef
28.
go back to reference Højsgaard S, Edwards D, Lauritzen S. Graphical Models with R.New York: Springer-Verlag; 2012.CrossRef Højsgaard S, Edwards D, Lauritzen S. Graphical Models with R.New York: Springer-Verlag; 2012.CrossRef
29.
go back to reference Sariego J. Regional variation in breast cancer treatment throughout the united states. Am J Surg. 2008; 196(4):572–4.CrossRefPubMed Sariego J. Regional variation in breast cancer treatment throughout the united states. Am J Surg. 2008; 196(4):572–4.CrossRefPubMed
30.
go back to reference Lakhani SR, Audretsch W, Cleton-Jensen AM, Cutuli B, Ellis I, Eusebi V, Greco M, Houslton RS, Kuhl CK, Kurtz J, et al.The management of lobular carcinoma in situ (lcis). Is LCIS the same as ductal carcinoma in situ (DCIS)?Eur J Cancer. 2006; 42(14):2205–11.CrossRefPubMed Lakhani SR, Audretsch W, Cleton-Jensen AM, Cutuli B, Ellis I, Eusebi V, Greco M, Houslton RS, Kuhl CK, Kurtz J, et al.The management of lobular carcinoma in situ (lcis). Is LCIS the same as ductal carcinoma in situ (DCIS)?Eur J Cancer. 2006; 42(14):2205–11.CrossRefPubMed
Metadata
Title
A Bayesian network and heuristic approach for systematic characterization of radiotherapy receipt after breast-conservation surgery
Authors
Milton Soto-Ferrari
Diana Prieto
Gitonga Munene
Publication date
01-12-2017
Publisher
BioMed Central
Published in
BMC Medical Informatics and Decision Making / Issue 1/2017
Electronic ISSN: 1472-6947
DOI
https://doi.org/10.1186/s12911-017-0479-4

Other articles of this Issue 1/2017

BMC Medical Informatics and Decision Making 1/2017 Go to the issue